When.com Web Search

  1. Ads

    related to: heparin vs lovenox for kidney

Search results

  1. Results From The WOW.Com Content Network
  2. Enoxaparin sodium - Wikipedia

    en.wikipedia.org/wiki/Enoxaparin_sodium

    Enoxaparin sodium, sold under the brand name Lovenox among others, is an anticoagulant medication (blood thinner). [11] It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. [ 11 ]

  3. Dalteparin sodium - Wikipedia

    en.wikipedia.org/wiki/Dalteparin_sodium

    Dalteparin is not superior to unfractionated heparin in preventing blood clots. [5] Heparins are cleared by the kidneys, but studies have shown that dalteparin does not accumulate even if kidney function is reduced. [6] Approximately 70% of dalteparin is excreted through kidneys based on animal studies. [7]

  4. Low-molecular-weight heparin - Wikipedia

    en.wikipedia.org/wiki/Low-molecular-weight_heparin

    As a result, patients with risks, such as the severely obese or in advanced stages of kidney failure, show decreased benefits due to fractionated heparin's increased half-life. [14] LMWHs should be used with extreme caution in patients undergoing any procedure involving spinal anesthesia / puncture , in conditions with increased risk of ...

  5. Heparin - Wikipedia

    en.wikipedia.org/wiki/Heparin

    Heparin, also known as unfractionated heparin (UFH), is a medication and naturally occurring glycosaminoglycan. [3] [4] Heparin is a blood anticoagulant that increases the activity of antithrombin. [5] It is used in the treatment of heart attacks and unstable angina. [3] It can be given intravenously or by injection under the skin. [3]

  6. Thrombosis prevention - Wikipedia

    en.wikipedia.org/wiki/Thrombosis_prevention

    A 2021 review found that low molecular weight heparin (LMWH) was superior to unfractionated heparin in the initial treatment of venous thromboembolism for people with cancer. [3] There are medication-based interventions and non-medication-based interventions. [4]

  7. Discovery and development of direct thrombin inhibitors

    en.wikipedia.org/wiki/Discovery_and_development...

    In the 1980s low molecular-weight heparin (LMWH) were developed. They are derived from heparin by enzymatic or chemical depolymerization and have better pharmacokinetic properties than heparin. [5] In 1955 the first clinical use of warfarin, a vitamin K antagonist, was reported. Warfarin was originally used as a rat poison in 1948 and thought ...